Clinical Trial Update: SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma [Phase 3]

View source ↗

Summary

A Clinical Trial Update for the Phase 3 SARC041 study comparing abemaciclib to placebo in patients with advanced dedifferentiated liposarcoma; the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Advanced Dedifferentiated Liposarcoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING